ReviewCureus2021

Cardiovascular Benefit of Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Type 2 Diabetes: A Systematic Review.

Petros Georgiou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.